Vivos Announces 4th Annual Breathing Wellness Conference in Cancún, Mexico, With Full Slate of World-Renowned Speakers
August 23, 2022 09:30 ET
|
Vivos Therapeutics
LITTLETON, Colo., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (NASDAQ: VVOS) ("Vivos") is excited to announce the fourth annual Breathing Wellness Conference, which will take place...
Vivos Inc Applies for Breakthrough Device Designation for Radiogel™
November 20, 2020 09:30 ET
|
Vivos Inc.
Richland WA, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced that it has completed its submission to the FDA seeking Breakthrough Device Designation for Radiogel™. ...
Vivos Inc. Summarizes the Health of Canine Therapy Patients Treated with IsoPet
March 04, 2019 07:00 ET
|
Vivos Inc.
Richland WA, March 04, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTCPINK: RDGL), provides a summary of the previous update on dogs that have been treated to date in the canine soft tissue sarcoma...
Vivos Inc. Reports on the Health of Canine Therapy Patients
February 25, 2019 07:00 ET
|
Vivos Inc.
Richland WA, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc. (OTCPINK: RDGL), a pharmaceutical company in the process of researching and developing minimally invasive...
Vivos, Inc. Completes Common Stock Equity Financing to Fund Roll Out of IsoPet™ and Eliminate Toxic Debt
October 10, 2018 07:00 ET
|
Vivos Inc.
Richland WA, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos, Inc. a pharmaceutical company researching and developing minimally invasive treatments to combat cancer in humans...
Vivos Inc Successfully Treats Canine Sarcoma with IsoPet™ (RadioGel™)
May 31, 2018 06:00 ET
|
Vivos Inc.
Richland, WA, May 31, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) successfully treated canine soft tissue sarcoma with its proprietary IsoPet™ (RadioGel™), a hydrogel liquid containing tiny...